
Please visit answersincme.com/TZA860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by James E. Galvin, MD, MPH. In this activity, an expert in Alzheimer’s disease (AD) discusses treatment of early AD with anti-amyloid therapies. Upon completion of this activity, participants should be better able to: Review the latest advances in anti-amyloid therapies for the treatment of early Alzheimer’s disease (AD; Assess the current evidence on anti-amyloid therapies, including maintenance strategies, for the treatment of early AD; and Outline strategies to integrate the latest advances in anti-amyloid therapies to practice to improve long-term outcomes for patients with early AD.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation

Novel and Emerging Oral GLP-1 RAs: Advancing Personalized Care for Canadians With Type 2 Diabetes

Case-Based Guidance on Tailoring Treatment Selection for Menopause-Related VMS

Sniffing Out Better Chronic Rhinosinusitis With Nasal Polyps Outcomes: Targeting Smell, Sleep, and Comorbidities With Biologics
Free AI-powered recaps of CME in Minutes: Education in Primary Care and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.